In CRPC, nuclear localization and overexpression of FOXA1 enhanced tumor growth and metastases by prompting cell cycle progression [12, 13, 14], whereas decreased luminal FOXA1 is associated with the promotion of NEPC [15, 16]. This evidence concerns the gene FOXA1 and neoplasm.